The Ohio Court of Appeals has upheld a lower court's decision to authorize the involuntary administration of psychiatric medication to Achyut Dhimal. The ruling, issued on August 10, 2026, affects Dhimal, who has been diagnosed with schizophrenia and faces serious criminal charges, including kidnapping and gross sexual imposition. This case raises important questions about the balance between individual rights and the need for mental health treatment.
In March 2024, Dhimal was indicted by a Butler County grand jury on multiple charges stemming from an alleged incident in which he broke into a home and assaulted a young woman. Following his arraignment, Dhimal filed a suggestion of incompetency and entered a plea of not guilty by reason of insanity. The trial court initially found him incompetent to stand trial and ordered him into treatment.
Over the next year, Dhimal's mental health fluctuated. After a review hearing in February 2025, the court found his competency restored. However, by May 2025, it was determined that he had decompensated and was again unable to stand trial. The State moved to retain jurisdiction, and the court ordered Dhimal to be placed at Summit Behavioral Healthcare.
While at the facility, Dr. James Xidas, Dhimal's treating psychiatrist, sought court approval to involuntarily administer 60 medications. A hearing was held on December 19, 2025, where Dr. Xidas testified that Dhimal's condition had worsened, leading to violent and threatening behavior. The court authorized the administration of 59 of the 60 medications, stating that it was in Dhimal's best interest and that no less intrusive treatment would be effective.
Dhimal appealed the ruling, arguing that the trial court had deprived him of due process by not appointing an independent psychiatrist to evaluate him before the decision was made. The court ruled that the trial court had not erred in its decision, stating, "The absence of an unrequested evaluation resulted in no miscarriage of justice." The ruling emphasized that Dhimal had the opportunity to be heard and did not request an independent evaluation during the hearing.
The court also addressed Dhimal's claim of ineffective assistance of counsel, concluding that his attorney's performance did not fall below an objective standard of reasonableness. The court noted that counsel had actively participated in the hearing and cross-examined Dr. Xidas, which contributed to the court's decision to strike one medication from the list.
This ruling has significant implications for individuals facing similar situations, particularly those with mental health issues who may be subject to involuntary treatment. The court's decision reinforces the legal standards surrounding the involuntary administration of medication, highlighting the importance of balancing individual rights with the need for effective treatment.
Going forward, this ruling may set a precedent for future cases involving the involuntary treatment of mentally ill individuals. It underscores the need for clear legal standards and protections for those who may be unable to advocate for themselves due to their mental health conditions. Dhimal's case may also prompt discussions about the adequacy of legal representation for individuals facing forced medication.
Details were not available in the court filing regarding potential next steps for Dhimal. However, the court's decision allows for the possibility of future hearings where Dhimal may invoke his right to an independent evaluation.